Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Miridesap (GSK2315698) is a divalent crosslinker of SAP that causes rapid depletion of circulating SAP via hepatic clearance. It also produces significant reduction of SAP from cerebrospinal fluid and visceral amyloid deposits
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 41.00 | |
10 mg | In stock | $ 66.00 | |
25 mg | In stock | $ 128.00 | |
50 mg | In stock | $ 192.00 | |
100 mg | In stock | $ 287.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 45.00 |
Description | Miridesap (GSK2315698) is a divalent crosslinker of SAP that causes rapid depletion of circulating SAP via hepatic clearance. It also produces significant reduction of SAP from cerebrospinal fluid and visceral amyloid deposits |
Synonyms | Ro63-8695, CPHPC, GSK2315698 |
Molecular Weight | 340.37 |
Formula | C16H24N2O6 |
CAS No. | 224624-80-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 75 mg/mL (220.35 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Miridesap 224624-80-0 Others Ro63-8695 GSK-2315698 CPHPC Inhibitor GSK 2315698 inhibit GSK2315698 inhibitor